<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000848.v1.p1" parentStudy="phs000848.v1.p1" createDate="2014-12-03" modDate="2014-12-11">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigators</td><td>Helen Su</td><td>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Principal Investigators</td><td>Sophie Hambleton</td><td>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Principal Investigators</td><td>Michael J. Lenardo</td><td>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Source</td><td>1ZIAAI001058-03</td><td>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Autosomal recessive TPP2 mutations cause a new human immunodeficiency</StudyNameEntrez>
	<StudyNameReportPage>Autosomal recessive <i>TPP2</i> mutations cause a new human immunodeficiency comprising recurrent infections, severe autoimmunity, and neurodevelopmental delay</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case-Control</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>To define a genetic syndrome of combined immunodeficiency, severe autoimmunity, and developmental delay, 4 patients from two families who had similar syndromic features were studied. To identify disease-causing mutations, we performed whole exome sequencing for one patient and her healthy parent from Family 1 and also for one patient from Family 2. Disease segregated with novel autosomal recessive mutations in a single gene, tripeptidyl-peptidase II (<i>TPP2</i>) gene. The result defines a new human metabolic immunodeficiency.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Patient samples were chosen for inclusion in the project based on the following criteria: <ol> <li>Families who had similar syndromic features were studied.</li> <li>Patients, parents and other family members are available.</li> <li>DNA was available for use in exome sequencing.</li> <li>Informed consent documentation.</li> </ol> </p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Journal authors="Lu W, Zhang Y, McDonald DO, Jing H, Carroll B, Robertson N, Zhang Q, Griffin H, Sanderson S, Lakey JH, Morgan NV, Reynard LN, Zheng L, Murdock HM, Turvey SE, Hackett SJ, Prestidge T, Hall JM, Cant AJ, Matthews HF, Koref MFS, Simon AK, Korolchuk VI, Lenardo MJ, Hambleton S, and Su HC." title="Dual proteolytic pathways govern glycolysis and immune competence." journal="Cell; <i>in press</i>."/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Immunologic Deficiency Syndromes"/>
		<Disease vocab_source="MESH" vocab_term="Autoimmunity"/>
		<Disease vocab_source="MESH" vocab_term="Developmental Disabilities"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigators">
			<AttName>Helen Su</AttName>
			<Institution>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Principal Investigators">
			<AttName>Sophie Hambleton</AttName>
			<Institution>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Principal Investigators">
			<AttName>Michael J. Lenardo</AttName>
			<Institution>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>1ZIAAI001058-03</AttName>
			<Institution>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="GRU" longName="General Research Use"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NIAID</DacName>
      <DacFullName>NIAID DAC</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000848.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>12</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000848.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000848.v1.p1" FileName="Model_DUC-TPPII.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use</ConsentName>
        <ConsentAbbrev>GRU</ConsentAbbrev>
        <UseLimitation>Use of the data is limited only by the terms of the model Data Use Certification.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
